Joel Greenblatt’s Amneal Pharmaceuticals AMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$201K Buy
+9,958
New +$179K ﹤0.01% 1803
2026
Q2
– Sell
-22,308
Closed -$277K – 1798
2026
Q1
$277K Buy
22,308
+2,785
+14% +$37.4K ﹤0.01% 1620
2025
Q4
$246K Sell
19,523
-6,137
-24% -$70.2K ﹤0.01% 1618
2025
Q3
$257K Sell
25,660
-34,543
-57% -$310K ﹤0.01% 1546
2025
Q2
$487K Buy
60,203
+7,534
+14% +$56.8K ﹤0.01% 1329
2025
Q1
$441K Sell
52,669
-35,214
-40% -$294K ﹤0.01% 1271
2024
Q4
$696K Buy
87,883
+40,224
+84% +$337K 0.01% 1029
2024
Q3
$397K Buy
+47,659
New +$373K ﹤0.01% 1159
2024
Q2
– Sell
-25,322
Closed -$153K – 1414
2024
Q1
$153K Buy
+25,322
New +$143K ﹤0.01% 1310
2021
Q4
– Sell
-10,629
Closed -$57K – 1135
2021
Q3
$57K Sell
10,629
-10,300
-49% -$51.9K ﹤0.01% 1002
2021
Q2
$107K Buy
+20,929
New +$119K ﹤0.01% 972
2020
Q4
– Sell
-11,503
Closed -$45K – 989
2020
Q3
$45K Sell
11,503
-660
-5% -$2.82K ﹤0.01% 1002
2020
Q2
$58K Sell
12,163
-1,213
-9% -$5K ﹤0.01% 1025
2020
Q1
$47K Sell
13,376
-1,102
-8% -$4.67K ﹤0.01% 1029
2019
Q4
$70K Buy
+14,478
New +$50.3K ﹤0.01% 1082
2019
Q3
– Sell
-30,883
Closed -$221K – 1082
2019
Q2
$221K Sell
30,883
-18,631
-38% -$190K ﹤0.01% 1044
2019
Q1
$702K Buy
+49,514
New +$654K 0.01% 759

Other funds holding AMRX

Joel Greenblatt's AMRX Position: Q3 2026 in Review

Joel Greenblatt opened a new position in Amneal Pharmaceuticals (AMRX) in Q3 2026: 9,958 shares worth $201K. The stake represents ﹤0.01% of the portfolio and ranks #1803 among its holdings. This is a return to the name: Joel Greenblatt previously reported a position in AMRX as recently as Q1 2026.

Joel Greenblatt first reported a position in AMRX in Q1 2019 and has held it in 17 quarters since. The position peaked at $702K in Q1 2019. 334 funds tracked by Wall St. Rank hold AMRX as of Q3 2026.

  • Joel Greenblatt held 9,958 shares of Amneal Pharmaceuticals worth $201K as of Q3 2026.
  • Amneal Pharmaceuticals was a new Joel Greenblatt position in Q3 2026.
  • Amneal Pharmaceuticals made up ﹤0.01% of Joel Greenblatt's portfolio in Q3 2026, its #1803 holding.
  • Joel Greenblatt first reported a position in Amneal Pharmaceuticals in Q1 2019 and has held it in 17 quarters since.
  • Joel Greenblatt's Amneal Pharmaceuticals position peaked at $702K in Q1 2019.
  • 334 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2026.

Based on Gotham Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.